AAAmirah Alnour

Amirah Alnour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amirah Alnour has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of 810 nm low-level laser therapy on muscle regeneration after bupivacaine-induced myonecrosis in a rabbit model

    by M. Talal Sadeldin, Omar Hamadah, Anas Abdo, Lana Sayal, Amirah Alnour

  • Open Access

    CD163 expression in M2 macrophages of primary and metastatic head and neck squamous cell carcinoma

    by Ahmad Abdulghani, Saleh Al Kurdi, Anas Abdo, Amirah Alnour

  • Open Access

    Pleomorphic adenoma: does the immunohistochemical profile direct the clinical profile: retrospective study and review of literature

    by Amirah Alnour

    Pleomorphic adenoma is a benign salivary gland tumor that has a potentiality to recurrence and malignant transformation as well. The genetic alteration of this tumor is not completely studied yet. Investigating the growth factor receptors and tumor microenvironment may yield answers to the nature of this tumor. Thirty-six formalin-fixed, paraffin-embedded pleomorphic adenoma specimens were collected from Al-Mouassat University Hospital. EGFR, HER-2 and BCL-2 antibodies have been used in immunohistochemistry stains to investigate the most probable affected pathway in this progress of this tumor. Immunohistochemical analysis revealed total negativity for HER2 expression. While, EGFR and BCL-2 expression was positive in diffuse patchy pattern. The positivity was membranous and/or cytoplasmic predominantly within the tumor cell population. Statistical analysis revealed no significant association between EGFR/BCL-2 expression and patient gender (p = 0.848) or tumor site (p = 1.000). The absence of HER2 expression was consistent across all cases, regardless of clinicopathological parameters. The expression of EGFR and BCL2 did not show a statistically significant correlation with demographic variables, suggesting a tumor-intrinsic expression pattern rather than dependence on clinical factors. On this study, pleomorphic adenoma demonstrated a distinct immune-profile with positivity of EGFR and BCL-2 and negative expression of HER-2. These findings suggest HER-2 unlikely contribute to tumor behavior, meanwhile the positivity of EGFR and BCL-2 may be related to the tumor survival rather than malignant transformation. Moreover, these markers do not same to consider as reliable predictors of malignant transformation in pleomorphic adenoma.

  • Open Access

    The Role of Chemopreventive Agents in the Management of Oral Potentially Malignant Disorders and Oral Cancer: A Narrative Review

    by Lana Sayal, Omar Hamadah, Eyad Chatty, Anas Abdo, Sana Aghbari, Ali Munasser, Amirah Alnour

    Background: Oral squamous cell carcinoma (OSCC) is a common and aggressive cancer sometimes subsequent to oral potentially malignant disorders (OPMDs). Notwithstanding progress in surgical, radiotherapeutic, and chemotherapeutic interventions, survival rates for OSCC continue to be inadequate and are associated with significant functional impairment, underscoring the necessity for preventive and interceptive therapeutic approaches. Chemoprevention has emerged as a viable strategy to inhibit, postpone, or reverse oral carcinogenesis by targeting the molecular and cellular processes implicated in malignant transformation. Recent Findings: This review synthesizes current evidence on chemopreventive agents investigated in OPMDs and OSCC. Relevant literature was analyzed focusing on natural compounds, synthetic drugs, and targeted biological therapies, as well as emerging delivery approaches. Significant emphasis is placed on bioactive phytochemicals such as retinoids, carotenoids (β‐carotene and lycopene), curcumin, resveratrol, black raspberries, and vitamin E, alongside synthetic agents including cyclooxygenase‐2 inhibitors and epidermal growth factor receptor (EGFR)–targeted therapies. These drugs demonstrate chemopreventive effects via modulating oxidative stress, inflammation, cell cycle regulation, apoptosis, angiogenesis, epithelial–mesenchymal transition, and immune evasion in the tumor microenvironment. Clinical and experimental investigations examined in this review reveal inconsistent, although promising results, including the regression of dysplasia, decreased rates of malignant transformation, and enhanced molecular risk profiles in OPMDs. Nonetheless, obstacles persist about long‐term effectiveness, ideal dose, toxicity, and patient adherence. Conclusion: Chemopreventive medicines, especially when utilised in combination and through sophisticated delivery systems, signify a prospective adjunct or alternative approach in the care of OPMDs and OSCC, with the capacity to diminish disease burden and enhance patient outcomes.

  • Open Access

    Mitochondrial D-loop variants and copy number alterations in saliva of basaloid squamous cell carcinoma patient: Can it be worth as a prognostic value? Case report

    by Lana Sayal, Anas Abdo, Hasan Alhouri, Eyad Chatty, Arwa Khir, Amirah Alnour

    Introduction: In the era of precision medicine, cell-free DNA (cfDNA) in saliva biopsies has emerged as a promising tool for cancer detection. The effects of D-loop variants, including D310, and circulating cell-free DNA (ccfDNA) copy number alterations in basaloid squamous cell carcinoma (BSCC) are poorly understood, so we conducted this research. Case presentation: We investigated the role of somatic variants of the D-loop region and copy number alterations in salivary ccfDNA of BSCC patients by using direct sequencing and real-time quantitative PCR. Mononucleotide repeat sequence between nucleotides 303 and 316–318 (D310) was identified in the mitochondrial DNA (mtDNA). Oxidative stress was elevated as well. We observed an increase in mtDNA copy number and homopolymeric C repeats in the mtDNA region (D310). An increase in mtDNA copy number may be an important event during the early phases of head and neck carcinogenesis. Clinical discussion: This research examines the role of mitochondrial D-loop mutations and copy number changes in saliva of basaloid squamous cell carcinoma (BSCC) patients and their utility as prognostic markers. This article highlights how cell-free DNA in saliva can be utilized for cancer detection and identifies some mitochondrial DNA characteristics like D310. There's a suggested association between elevated mtDNA copy numbers and early stages of head and neck cancer development. Conclusion: Salivary ccfDNA could serve as a novel and easily accessible non-invasive biomarker in BSCC, providing diagnostic and prognostic value. Highlights:


  • Open Access

    Head and Neck Plasmacytoma With Diffuse Amyloid Deposition: A Case Report

    by Amirah Alnour, Mohammad-Aasem Abbas, Ameen Rahmoun, Zein Ibrahimbasha, Lana Sayal, Marco Isaac, Khaldoun Darwich, Zaven Karabet, Anas Abdo

    A variety of carcinogenic agents and the innovation of diagnostic methods have a huge impact on the biological profile of numerous tumors over time which reflect in their diagnosis and behavior. The ability to predict the tumors′ behavior, mainly the malignant ones, and develop personalized therapy could change the lifestyle of the patients. The unpredictable histopathologic profile of plasmacytoma, for example, and its linked clinical behavior suggest that the fluctuations are linked to its behavior and prognosis as well. We introduce in this case a unique type of plasmacytoma with valuable clinical data and follow‐up that may support literature with conspicuous documented cases of this malignant tumor. Indeed, this entity has obvious invasive and destructive features and yet a good prognosis. A good understanding of this malignancy will extremely enhance the long‐term healing of the patients. This paper presents a destructive plasmacytoma with peculiar histopathologic features and yet has a good prognosis during our follow‐up. We observed a multinodular mass in the right mandible extending above the sternocleidomastoid muscle in a 58‐year‐old female patient who was referred to the oral and maxillofacial department in the faculty. After half‐mandible excision and right neck resection, the lesion was diagnosed as a plasmacytoma with amyloid deposition, and the patient was referred to an oncologist. And the patient is still under follow‐up without any recurrence. Despite the low risk of extramedullary plasmacytoma progressing into multiple myeloma, the clinical management is still a challenge because of the potential for recurrence. Understanding the behavior of this tumor and its management strategies is crucial to obtain the best prognosis for the patients.

  • Open Access

    Troxerutin effect on gastric ulcers induced by ketorolac in rats: Relation with oxidative stress

    by Alaa Zouher Darkazally, Amirah Alnour, Shadi Homsi


  • Open Access

    ‘Misdiagnosis of diffuse large B-cell lymphoma in the maxillary sinus as a dental abscess’

    by Obai Jabr, Sentia Haddad, Mumdouh Almohareb, Omar Al-Rashdan, Zein Basha, Sultaneh Haddad, Fouad Jaber, Walaa Mohamed Jasim Radhi Ali, Amirah Alnour

    Introduction: Diffuse large B-cell Lymphoma (DLBCL) is a heterogeneous group of malignant tumors with diverse prognoses, histological appearances, and clinical symptoms. While it commonly affects lymphoid tissues, its occurrence in the nasal cavity and paranasal sinuses is rare and poses significant diagnostic challenges. Case Presentation: The authors present a case of a 53-year-old man with a history of testicular non-Hodgkin lymphoma treated 5 months prior. He presented with symptoms initially misdiagnosed as a dental abscess, which was later identified as DLBCL in the maxillary sinus. Discussion: The etiology of primary lymphoma in the oral region remains unclear. Due to its rarity, specific prognostic factors, and optimal treatment strategies are not well-established. This case highlights the diagnostic challenges and underscores the importance of considering lymphoma in the differential diagnosis of nonresponsive dental abscesses. Conclusion: This case underscores the importance of thorough investigation in patients with nonresponsive dental abscesses. Early identification and appropriate management of DLBCL in uncommon sites require heightened clinical awareness and interdisciplinary collaboration. The optimal treatment approach remains debated and warrants further research.


  • Open Access

    Post-endodontic pain in curved canals prepared with different rotary instrumentation techniques: A randomized controlled trial

    by Liana Kinjrawi, Anas Abdo, Amirah Alnour, Hassan Achour, Mohamad Salem Rekab

    Curved root canals are associated with the highest number of procedural errors during endodontic instrumentation. Recently, numerous rotary instruments have been developed, with both manual and automated mechanisms, to facilitate endodontic treatment and manage the complications related to it. The aim of the study was to assess post-endodontic pain after using the HyFlex® EDM OneFile (HEDM), WaveOne® Gold (WOG) and XP-endo® Shaper (XPS) systems in the preparation of curved canals in patients with asymptomatic irreversible pulpitis. A total of 45 molars with curved canals and asymptomatic irreversible pulpitis were randomly divided into 3 equal groups based on the instrumentation used: HEDM (group A); WOG (group B); and XPS (group C). All teeth were prepared according to the manufacturers' instructions. Postendodontic pain was assessed using the visual analog scale (VAS) at 6, 12, 18, 24, 48, and 72 h after root canal instrumentation. The data was analyzed using the one-way analysis of variance (ANOVA) and the paired-samples t test with the Bonferroni correction, with a p-value of 0.05 set for statistical significance. The highest levels of post-endodontic pain were recorded at 6 h after treatment. Then, the values gradually decreased until the pain nearly vanished after 72 h. No statistically significant differences were observed in the VAS scores between groups A and B. At the same time, group C showed the lowest VAS scores at all follow-up time points. The use of the XPS system resulted in the lowest pain scores at all follow-ups. The HEDM and WOG groups showed no differences in the pain scores throughout the whole follow-up period.